VEA
ITCI
Virtus ETF Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,193
| Closed | -$350K | – | 697 |
|
|
2024
Q4 | $350K | Sell |
4,193
-621
| -13% | -$51.9K | 0.14% | 199 |
|
|
2024
Q3 | $352K | Hold |
4,814
| – | – | 0.16% | 215 |
|
|
2024
Q2 | $330K | Sell |
4,814
-1,019
| -17% | -$69.8K | 0.16% | 212 |
|
|
2024
Q1 | $404K | Buy |
5,833
+839
| +17% | +$58.1K | 0.21% | 193 |
|
|
2023
Q4 | $358K | Buy |
4,994
+271
| +6% | +$19.4K | 0.23% | 183 |
|
|
2023
Q3 | $246K | Sell |
4,723
-613
| -11% | -$31.9K | 0.15% | 227 |
|
|
2023
Q2 | $338K | Sell |
5,336
-504
| -9% | -$31.9K | 0.2% | 171 |
|
|
2023
Q1 | $316K | Buy |
5,840
+107
| +2% | +$5.79K | 0.17% | 192 |
|
|
2022
Q4 | $303K | Buy |
5,733
+1,376
| +32% | +$72.8K | 0.16% | 260 |
|
|
2022
Q3 | $203K | Buy |
4,357
+61
| +1% | +$2.84K | 0.08% | 319 |
|
|
2022
Q2 | $245K | Sell |
4,296
-6,123
| -59% | -$349K | 0.09% | 304 |
|
|
2022
Q1 | $638K | Hold |
10,419
| – | – | 0.29% | 107 |
|
|
2021
Q4 | $545K | Sell |
10,419
-284
| -3% | -$14.9K | 0.21% | 108 |
|
|
2021
Q3 | $399K | Sell |
10,703
-976
| -8% | -$36.4K | 0.18% | 176 |
|
|
2021
Q2 | $477K | Sell |
11,679
-13,085
| -53% | -$534K | 0.2% | 164 |
|
|
2021
Q1 | $840K | Buy |
24,764
+679
| +3% | +$23K | 0.35% | 98 |
|
|
2020
Q4 | $766K | Buy |
24,085
+8,782
| +57% | +$279K | 0.32% | 90 |
|
|
2020
Q3 | $393K | Sell |
15,303
-2,089
| -12% | -$53.6K | 0.21% | 172 |
|
|
2020
Q2 | $446K | Sell |
17,392
-10,658
| -38% | -$273K | 0.21% | 164 |
|
|
2020
Q1 | $431K | Sell |
28,050
-4,089
| -13% | -$62.8K | 0.18% | 187 |
|
|
2019
Q4 | $1.1M | Buy |
32,139
+11,942
| +59% | +$410K | 0.18% | 150 |
|
|
2019
Q3 | $151K | Sell |
20,197
-1,125
| -5% | -$8.41K | 0.03% | 276 |
|
|
2019
Q2 | $277K | Buy |
21,322
+2,444
| +13% | +$31.8K | 0.06% | 253 |
|
|
2019
Q1 | $230K | Sell |
18,878
-2,735
| -13% | -$33.3K | 0.49% | 82 |
|
|
2018
Q4 | $246K | Sell |
21,613
-645
| -3% | -$7.34K | 0.04% | 163 |
|
|
2018
Q3 | $483K | Sell |
22,258
-15,916
| -42% | -$345K | 0.05% | 129 |
|
|
2018
Q2 | $675K | Sell |
38,174
-11,914
| -24% | -$211K | 0.6% | 111 |
|
|
2018
Q1 | $1.05M | Buy |
50,088
+26,986
| +117% | +$568K | 0.91% | 33 |
|
|
2017
Q4 | $335K | Sell |
23,102
-7,498
| -25% | -$109K | 0.42% | 109 |
|
|
2017
Q3 | $483K | Buy |
30,600
+2,799
| +10% | +$44.2K | 0.07% | 92 |
|
|
2017
Q2 | $345K | Buy |
27,801
+9,472
| +52% | +$118K | 0.05% | 89 |
|
|
2017
Q1 | $298K | Buy |
18,329
+1,757
| +11% | +$28.6K | 0.05% | 135 |
|
|
2016
Q4 | $250K | Buy |
16,572
+10,129
| +157% | +$153K | 0.07% | 142 |
|
|
2016
Q3 | $98K | Hold |
6,443
| – | – | 0.05% | 151 |
|
|
2016
Q2 | $250K | Buy |
+6,443
| New | +$250K | 0.19% | 87 |
|